Skip to main content
Livermore
Livermore
ZHEN

Morgan Stanley

SEC CIK
0000895421
Latest filing
Aug 13, 2026

IBIO holding history

iBio, Inc. in every 13F filed by Morgan Stanley, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

IBIO overviewAll 13F holders of IBIOFull Q2 2026 holdings

Shares (Q2 2026)
10
Value
$18
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of IBIO by Morgan Stanley, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202610$18<0.1%−30,927−100.0%ReducedHolders
Q1 202630,937$58.8K<0.1%+3,342+12.1%AddedHolders
Q4 202527,595$53.3K<0.1%+27,538+48,312.3%AddedHolders
Q3 202557$47<0.1%+8+16.3%AddedHolders
Q2 202549$38<0.1%−3,726−98.7%ReducedHolders
Q1 20253,775$15.2K<0.1%+3,727+7,764.6%AddedHolders
Q4 202448$117<0.1%00.0%UnchangedHolders
Q3 202448$107<0.1%−1−2.0%ReducedHolders
Q2 202449$103<0.1%−219−81.7%ReducedHolders
Q1 2024268$1.09K<0.1%−71−20.9%ReducedHolders
Q4 2023339$464<0.1%−24−6.5%ReducedConverted for a 1-for-20 splitHolders
Q3 20237,254$2.20K<0.1%+103+1.4%AddedHolders
Q2 20237,151$4.36K<0.1%+5,118+251.7%AddedHolders
Q1 20232,033$4.23K<0.1%−5,098−71.5%ReducedHolders
Q4 20227,131$3.17K<0.1%+4,668+189.5%AddedConverted for a 1-for-25 splitHolders
Q3 202261,575$11.0K<0.1%−271,779−81.5%ReducedHolders
Q2 2022333,354$88.0K<0.1%+181,600+119.7%AddedHolders
Q1 2022151,754$64.0K<0.1%−7,764−4.9%ReducedHolders
Q4 2021159,518$86.0K<0.1%+29,207+22.4%AddedHolders
Q3 2021130,311$138.0K<0.1%−32,033−19.7%ReducedHolders
Q2 2021162,344$244.0K<0.1%+57,941+55.5%AddedHolders
Q1 2021104,403$161.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.